CM
FOLD

Caption Management’s Amicus Therapeutics FOLD Stock Holding History

Caption Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,100
Closed -$109K – 1747
2025
Q3 		$87.5K Buy
11,100
+1,400
+14% +$9.96K ﹤0.01% 1542
2025
Q2 		$55.6K Sell
9,700
-159,951
-94% -$1.03M ﹤0.01% 1343
2025
Q1 		$1.38M Buy
169,651
+74,651
+79% +$691K 0.01% 810
2024
Q4 		$895K Buy
+95,000
New +$987K 0.01% 951
2024
Q3 		– Sell
-21,900
Closed -$217K – 1393
2024
Q2 		$217K Buy
+21,900
New +$225K ﹤0.01% 944
2024
Q1 		– Sell
-299,500
Closed -$3.83M – 1352
2023
Q4 		$4.25M Buy
299,500
+272,500
+1,009% +$3.09M 0.06% 387
2023
Q3 		$328K Buy
27,000
+23,287
+627% +$300K 0.01% 1026
2023
Q2 		$46.6K Buy
+3,713
New +$44.1K ﹤0.01% 1012
2022
Q4 		– Sell
-33,400
Closed -$376K – 1415
2022
Q3 		$349K Buy
+33,400
New +$372K ﹤0.01% 1142
2021
Q3 		– Sell
-47,861
Closed -$490K – 1602
2021
Q2 		$461K Buy
+47,861
New +$467K 0.01% 1056
2021
Q1 		– Sell
-199,654
Closed -$3.09M – 1166
2020
Q4 		$4.61M Buy
199,654
+36,854
+23% +$754K 0.11% 244
2020
Q3 		$2.3M Buy
162,800
+110,974
+214% +$1.62M 0.05% 391
2020
Q2 		$783K Buy
51,826
+34,126
+193% +$416K 0.03% 584
2020
Q1 		$163K Buy
+17,700
New +$168K 0.01% 721
2019
Q4 		– Sell
-15,000
Closed -$119K – 898
2019
Q3 		$119K Buy
+15,000
New +$163K 0.01% 632
2018
Q2 		– Sell
-10,000
Closed -$151K – 404
2018
Q1 		$151K Buy
+10,000
New +$152K 0.02% 207

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Caption Management's FOLD Position: Q4 2025 in Review

Caption Management sold out of Amicus Therapeutics (FOLD) in Q4 2025, closing a stake of 11,100 shares — an estimated $109K sold.

Caption Management first reported a position in FOLD in Q1 2018 and held it in 16 quarters. The position peaked at $4.61M in Q4 2020. 332 funds tracked by Wall St. Rank hold FOLD as of Q4 2025.

  • Caption Management reported no remaining Amicus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Caption Management sold 11,100 Amicus Therapeutics shares in Q4 2025, an estimated $109K.
  • Caption Management first reported a position in Amicus Therapeutics in Q1 2018 and held it in 16 quarters.
  • Caption Management's Amicus Therapeutics position peaked at $4.61M in Q4 2020.
  • 332 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.